Introducing OncoFlow-Profiler: our state-of-the-art high-throughput screening solution crafted to fast-track the detection of your target antigen expression in a well-established panel of 160 cancer cell lines. Within just 2 weeks, you can obtain high-quality flow cytometry data, facilitating early informed decisions in the ADC drug discovery process.
Why choose OncoFlow-Profiler?
High-throughput screening platform, with access to 160 well-established cancer cell lines
Quick turnaround; get results within 2 weeks
Detects carbohydrate-based antigens, remarkably adept at detecting subtle post-translational modifications
Accurate and reliable results reflecting years of protocol optimization
Discover our be-spoke experimental workflow
We assure top-quality data, a testament to years of protocol validation and optimization
Each stage of our experimental protocol is rigorously validated. Through careful internal validation of our protocols, we aim to provide data of the utmost quality. In the following graphs, we present a typical validation study focusing on the expression of HER2 as a target antigen. This study examines the impact of fixation and assesses the stability of the OncoFlow-Profiler vials under various storage conditions. Furthermore, we highlight a strong correlation between OncoFlow-Profiler data and gene amplification data, underscoring its reliability.
stability of the the HER2 receptor
over time in different storage conditions
data with gene amplification data
Take the guesswork out of target antigen expression
Reach out to explore the power of OncoFlow-Profiler now.